IL37 and hepatocellular carcinoma: IL-37 has been shown to be protective during the development of a number of cancers, including hepatocellular carcinoma (43), colorectal cancer (44), non-small cell lung cancer, renal cell carcinoma and oral and cervical squamous cell carcinoma (45).